Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Cartel
A number of organisations operating in a market to minimise competition or gain overall control.
Cartel members most commonly concur on price fixing, shared industry output, market shares, allotment of customers, distribution of regions and the division of profits or the combined results of these. The aim of a cartel is to maximise individual members' profits by minimising competition.
See also:
Market share
Price fixing
Related terms
Background, Penetrated market, Advertising agency's commission, Monopoly, Market research, Trend analysis, Business portfolio, Generic medicine, Bias, Corporate strategy, Brand extension , Local advertising, Post detail survey, Niche marketing, Motivation research,
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Account Manager
-
Competitive salary with bonus and benefits
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- GSK appoint Tony Wood as chief scientific officer
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Almirall and IRB Barcelona announce new research collaboration
- Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
- ARISE - a strategic healthcare communication planning process from Bedrock
- Pfizer and BioNTech start clinical trial for Omicron-based COVID-19 vaccine
- FDA restricts use of certain antibody treatments for COVID-19
- Let's explore new frontiers
- FDA grants priority review for Roche’s Evrysdi for spinal muscular atrophy in babies
- Ipsen’s Sohonos approved by Health Canada
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Why pharma must get smart in its approach to customer engagement
- WHITE PAPER: Gender inequality—how COVID-19 impacted women
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Almirall and IRB Barcelona announce new research collaboration
- AstraZeneca's Enhertu receives FDA grant for priority review
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
